Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-04

Clinical Trial Update: Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response [NA]

View source ↗

Summary

A clinical trial investigating propranolol for autism in adults and adolescents has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Autism | NA | Status: WITHDRAWN